Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Actinium Pharmaceuticals, Inc. (ATNM) had Cash Flow from Investing Activities of $-0.48M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$35.00M |
|
$27.90M |
|
-- |
|
$35.00M |
|
$7.43M |
|
$27.57M |
|
$0.34M |
|
$27.90M |
|
$27.90M |
|
$27.90M |
|
$27.90M |
|
$27.90M |
|
$27.90M |
|
$27.57M |
|
$27.81M |
|
31.40M |
|
31.41M |
|
$0.89 |
|
$0.89 |
|
| Balance Sheet Financials | |
$37.74M |
|
$0.70M |
|
$2.42M |
|
$40.16M |
|
$9.26M |
|
-- |
|
$0.59M |
|
$9.86M |
|
$30.30M |
|
$30.30M |
|
$30.30M |
|
31.44M |
|
| Cash Flow Statement Financials | |
$-11.05M |
|
|
Cash Flow from Investing Activities |
$-0.48M |
$-0.01M |
|
$48.33M |
|
$36.81M |
|
$-11.52M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.08 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
78.76% |
|
78.76% |
|
-- |
|
79.72% |
|
79.72% |
|
$-11.53M |
|
-- |
|
-- |
|
-- |
|
0.87 |
|
-- |
|
-- |
|
-- |
|
92.08% |
|
92.08% |
|
69.48% |
|
92.08% |
|
$0.96 |
|
$-0.37 |
|
$-0.35 |
|